Biomedical Engineering Reference
In-Depth Information
75. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, Wijelath
ES. Expression of vascular endothelial growth factor receptors in smooth
muscle cells. J Cell Physiol 2001; 188:359-368.
76. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN,
et al. Comparative effects of basic fibroblast growth factor and vascular
endothelial growth factor on coronary collateral development and the arterial
response to injury. Circulation 1996; 94:1074-1082.
77. Celletti FL, Hilfiker PR, Ghafouri P, Dake MD. Effect of human recombinant
vascular endothelial growth factor165 on progression of atherosclerotic
plaque. J Am Coll Cardiol 2001; 37:2126-2130.
78. Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD.
Vascular endothelial growth factor enhances atherosclerotic plaque progres-
sion. Nat Med 2001; 7:425-429.
79. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, et al. Vascular
endothelial growth factor (VEGF) expression in human coronary athero-
sclerotic lesions: possible pathophysiological significance of VEGF in progres-
sion of atherosclerosis. Circulation 1998; 98:2108-2116.
80. He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB. Vascular
endothelial growth factor signals endothelial cell production of nitric oxide
and prostacyclin through flk-1
=
KDR activation of c-Src. J Biol Chem 1999;
274:25130-25135.
81. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and
the VEGF receptors KDR
=
FIk and Fit in lungs exposed to acute or to chronic
hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995;
95:1798-1807.
82. Kitamoto S, Egashira K, Kataoka C, Koyanagi M, Katoh M, Shimokawa H,
et al. Increased activity of nuclear factor-kappaB participates in cardiovascu-
lar remodeling induced by chronic inhibition of nitric oxide synthesis in rats.
Circulation 2000; 102:806-812.
83. Zhao Q, Egashira K, Inoue S, Usui M, Kitamoto S, Ni W, et al. Vascular
endothelial growth factor is necessary in the development of arteriosclerosis
by recruiting
=
activating monocytes in a rat model of long-term inhibition of
nitric oxide synthesis. Circulation 2002; 105:1110-1115.
84. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67:
753-791.
85. Coker RK, Laurent GJ, Shahzeidi S, Hernandez-Rodriguez NA, Pantelidis P,
du Bois RM, Jeffery PK, McAnuity RJ. Diverse cellular TGF-beta 1 and
TGF-beta 3 gene expression in normal human and murine lung. Eur Respir
J 1996; 9:2501-2507.
86. Corrin B, Butcher D, McAnuity BJ, Dubois RM, Black CM, Laurent GJ,
Harrison NK. Immunohistochemical localization of transforming growth
factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic
fibrosing alveolitis and other lung disorders. Histopathology 1994; 24:
145-150.
87.
Jagirdar J, Begin R, Dufresne A, Goswami S, Lee TC, Rom WN. Transform-
ing growth factor-beta (TGF-beta) in silicosis. Am J Respir Crit Care Med
1996; 154:1076-1081.
